These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1763131)

  • 1. [The effect of (+) and (-)-propranolol in high doses on selected heart-circulatory parameters in the rat].
    Kittner H; Fischer W; Poelchen W
    Pharmazie; 1991 Jun; 46(6):470-1. PubMed ID: 1763131
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of propranolol and alcohol on hemodynamics and fatality in the rat].
    Hepp A
    Z Kardiol; 1985 May; 74(5):261-5. PubMed ID: 4013461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heart and circulatory dynamics of the dog under the effect of the beta-receptor blocking agent propranolol].
    Gersmeyer EF; Beyer E; Leicht E; Spitzbarth H
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(1):85-96. PubMed ID: 4871304
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of propranolol on the hypotensive action of ketanserin in normotensive rats.
    Malinowska B; Pietraszek M; Chabielska E; Buczko W
    Acta Physiol Pol; 1989; 40(4):356-62. PubMed ID: 2485607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term propranolol therapy in essential circulatory hyperkinesis.
    Török E; Bajkay G; Gulyás A; Istvánffy M; Matos L
    Int J Clin Pharmacol; 1972 Nov; 6(4):364-74. PubMed ID: 4629827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic studies on digitalis sensitivity using dye dilution method].
    Watarai M
    Jpn Circ J; 1969 Nov; 33(11):1357-70. PubMed ID: 4909968
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardiovascular effects of protamine in rats and isolated rat heart.
    Kertesz R; Walker MJ
    Proc West Pharmacol Soc; 1993; 36():53-7. PubMed ID: 8378398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Propranolol effect on hemodynamic and respiratory functional data in various submaximal stress in healthy persons].
    Sziegoleit W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Teichmann W; Enke H
    Z Gesamte Inn Med; 1973 Dec; 28(23):719-24. PubMed ID: 4786173
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of beta sympathetic blockade on the initial hemodynamic response to exercise.
    Smulyan H; Eich RH
    J Lab Clin Med; 1968 Mar; 71(3):378-89. PubMed ID: 4868950
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
    Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
    Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical relationship between the superior cervical ganglia and the antihypertensive action of propranolol in the spontaneous hypertensive rat.
    Tuttle R; Elias B; McCleary M; Endy T
    J Pharmacol Exp Ther; 1982 Dec; 223(3):824-33. PubMed ID: 7143243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the early circulatory effects of triiodothyronine in rats by propranolol.
    Kapitola J; Vilimovská D
    Physiol Bohemoslov; 1981; 30(4):347-51. PubMed ID: 6458055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in hemodynamics under the effect of two beta sympathicolytics of various pharmacodynamic principle].
    Lang E; Holtmann W
    Arzneimittelforschung; 1974 Sep; 24(9):1330-5. PubMed ID: 4479799
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of propranolol and midazolam therapy on hemodynamic parameters in rabbits.
    Wiktorowska-Owczarek A; Owczarek J; Obolewska A; Orszulak-Michalak D
    Med Sci Monit; 2000; 6(5):896-900. PubMed ID: 11208429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.